Maraviroc Plus Darunavir/Ritonavir Study for Treatment-Naive Patients Infected With R5-tropic HIV-1 Based on Enhanced Sensitivity Trofile.
Phase of Trial: Phase II
Latest Information Update: 15 Oct 2014
At a glance
- Drugs Darunavir (Primary) ; Maraviroc (Primary) ; Ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms MIDAS
- 10 Jun 2017 Biomarkers information updated
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jul 2012 Planned End Date changed from 1 Jan 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.